{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T04:09:00Z","timestamp":1743307740126,"version":"3.40.3"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T00:00:00Z","timestamp":1743120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T00:00:00Z","timestamp":1743120000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Fundaci\u00f3n Enebro","award":["232021 program"],"award-info":[{"award-number":["232021 program"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Gaucher disease can have effects on the development of pregnancy, childbirth, and lactation, with impact on health of both the mother and the newborn. Management of pregnancies in Gaucher patients is further complicated by using of enzyme replacement therapy. Unfortunately, the available scientific evidence is not conclusive because there are not proper clinical trials on this issue. The aim of this work was to establish a management guide to address the main clinical problems before, during and after pregnancy and to provide key information to healthcare professionals, patients, and families. GRADE methodology to evaluate the quality of scientific evidence and develop recommendations was incorporated to elaborate this guide. For final recommendations, a structured consensus 2-round process was carried out using the Delphi method with a Gaucher expert panel. After this process, nine recommendations were elaborated related to pre-pregnant status and genetic counseling and for management during pregnancy, seven related to childbirth, and eight focused on management after delivery and breastfeeding. Regarding the quality of the evidence, values and preferences of patients were also considered. A consensus guide to define and standardize pregnancy management in Gaucher disease considering the best available evidence, complemented by experts\u2019 opinions, could be a relevant tool to help patients, nurses, midwives and physicians with little experience in Gaucher disease who do not have access to guidance from Gaucher disease treatment centers of excellence.<\/jats:p>","DOI":"10.1186\/s13023-025-03684-6","type":"journal-article","created":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T13:51:43Z","timestamp":1743256303000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Spanish consensus on managing pregnancy in women with Gaucher disease"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3166-5086","authenticated-orcid":false,"given":"Enrique J.","family":"Calder\u00f3n","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicia","family":"Rodr\u00edguez-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"Calder\u00f3n-Baturone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"Aporta-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco J.","family":"del Castillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lutgardo","family":"Garc\u00eda-D\u00edaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Gonz\u00e1lez-Meneses","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Lourdes","family":"Hermos\u00edn-Ramos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raquel","family":"Yahyaoui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ignacio","family":"Mar\u00edn-Le\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,28]]},"reference":[{"key":"3684_CR1","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.cbpa.2019.10.006","volume":"53","author":"JMFG Aerts","year":"2019","unstructured":"Aerts JMFG, Kuo CL, Lelieveld LT, van der Boer DEC, Overkleeft HS, Artola M. Glycosphingolipids and lysosomal storage disorders as illustrated by gaucher disease. Curr Opin Chem Biol. 2019;53:204\u201315. https:\/\/doi.org\/10.1016\/j.cbpa.2019.10.006.","journal-title":"Curr Opin Chem Biol"},{"key":"3684_CR2","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1080\/10245332.2016.1240391","volume":"22","author":"L Nalysnyk","year":"2017","unstructured":"Nalysnyk L, Rotella P, Simeone JC, Hamed A, Weinreb N. Gaucher disease epidemiology and natural history: a comprehensive review of the literature. Hematology. 2017;22:65\u201373. https:\/\/doi.org\/10.1080\/10245332.2016.1240391.","journal-title":"Hematology"},{"key":"3684_CR3","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.ymgme.2020.12.295","volume":"132","author":"NJ Weinreb","year":"2021","unstructured":"Weinreb NJ, Camelo JS Jr, Charrow J, McClain MR, Mistry P, Belmatoug N, International Collaborative Gaucher Group. (ICGG) gaucher registry NCT00358943) investigators. gaucher disease type 1 patients from the ICGG gaucher registry sustain initial clinical improvements during Twenty years of imiglucerase treatment. Mol Genet Metab. 2021;132:100\u201311. https:\/\/doi.org\/10.1016\/j.ymgme.2020.12.295.","journal-title":"Mol Genet Metab"},{"key":"3684_CR4","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.ajog.2003.08.006","volume":"190","author":"Y Elstein","year":"2004","unstructured":"Elstein Y, Eisenberg V, Granovsky-Grisaru S, Rabinowitz R, Samueloff A, Zimran A, Elstein D. Pregnancies in gaucher disease: a 5-year study. Am J Obstet Gynecol. 2004;190:435\u201341. https:\/\/doi.org\/10.1016\/j.ajog.2003.08.006.","journal-title":"Am J Obstet Gynecol"},{"issue":"4 Pt 1","key":"3684_CR5","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1016\/0002-9378(95)91494-3","volume":"172","author":"S Granovsky-Grisaru","year":"1995","unstructured":"Granovsky-Grisaru S, Aboulafia Y, Diamant YZ, Horowitz M, Abrahamov A, Zimran A. Gynecologic and obstetric aspects of Gaucher\u2019s disease: a survey of 53 patients. Am J Obstet Gynecol. 1995;172(4 Pt 1):1284\u201390. https:\/\/doi.org\/10.1016\/0002-9378(95)91494-3.","journal-title":"Am J Obstet Gynecol"},{"key":"3684_CR6","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.ejogrb.2020.09.027","volume":"254","author":"V Komninaka","year":"2020","unstructured":"Komninaka V, Flevari P, Marinakis T, Karkaletsis G, Malakou L, Repa K. Outcomes of pregnancies in patients with gaucher disease: the experience of a center of excellence on rare metabolic Disease-Gaucher disease, in Greece. Eur J Obstet Gynecol Reprod Biol. 2020;254:181\u20137. https:\/\/doi.org\/10.1016\/j.ejogrb.2020.09.027.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"3684_CR7","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.bcmd.2016.10.003","volume":"68","author":"H Lau","year":"2018","unstructured":"Lau H, Belmatoug N, Deegan P, Goker-Alpan O, Schwartz IVD, Shankar SP, Panahloo Z, Zimran A. Reported outcomes of 453 pregnancies in patients with gaucher disease: an analysis from the gaucher outcome survey. Blood Cells Mol Dis. 2018;68:226\u201331. https:\/\/doi.org\/10.1016\/j.bcmd.2016.10.003.","journal-title":"Blood Cells Mol Dis"},{"key":"3684_CR8","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.pog.2014.04.002","volume":"57","author":"IA Perdomo Amar","year":"2014","unstructured":"Perdomo Amar IA, Solano Trujillo MH. Evoluci\u00f3n cl\u00ednica y paracl\u00ednica de 9 embarazos En 4 Pacientes Con Enfermedad de gaucher Tipo 1 En El servicio de hematolog\u00eda de Un hospital Docente asistencial. Prog Obstet Ginecol. 2014;57:362\u20137.","journal-title":"Prog Obstet Ginecol"},{"key":"3684_CR9","first-page":"852","volume":"83","author":"R Aporta-Rodr\u00edguez","year":"1998","unstructured":"Aporta-Rodr\u00edguez R, Escobar-Vedia JL, Navarro-Castro AM, Aguilar-Garc\u00eda G, Cabrera-Torres A. Alglucerase enzyme replacement therapy used safely and effectively throughout the whole pregnancy of a gaucher disease patient. Haematologia. 1998;83:852\u201364.","journal-title":"Haematologia"},{"key":"3684_CR10","first-page":"278","volume":"30","author":"H Aladag","year":"2023","unstructured":"Aladag H, Aladag M. Nine healthy deliveries in four pregnant women with enzyme replacement therapy in gaucher disease. Ann Med Res. 2023;30:278\u201381.","journal-title":"Ann Med Res"},{"key":"3684_CR11","doi-asserted-by":"publisher","first-page":"556143","DOI":"10.19080\/JGWH.2023.23.556143","volume":"24","author":"A Suraksha","year":"2023","unstructured":"Suraksha A, Fraha K. Gaucher disease and reproduction. J Gynecol Women\u2019s Health. 2023;24:556143. https:\/\/doi.org\/10.19080\/JGWH.2023.23.556143.","journal-title":"J Gynecol Women\u2019s Health"},{"key":"3684_CR12","doi-asserted-by":"publisher","first-page":"e15149","DOI":"10.7759\/cureus.15149","volume":"13","author":"P Patel","year":"2021","unstructured":"Patel P, Balanchivadze N. Hematologic findings in pregnancy: A guide for the internist. Cureus. 2021;13:e15149. https:\/\/doi.org\/10.7759\/cureus.15149.","journal-title":"Cureus"},{"key":"3684_CR13","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1182\/blood-2017-05-781971","volume":"130","author":"DB Cines","year":"2017","unstructured":"Cines DB, Levine LD. Thrombocytopenia in pregnancy. Blood. 2017;130:2271\u20137. https:\/\/doi.org\/10.1182\/blood-2017-05-781971.","journal-title":"Blood"},{"key":"3684_CR14","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.bcmd.2009.04.003","volume":"43","author":"A Zimran","year":"2009","unstructured":"Zimran A, Morris E, Mengel E, Kaplan P, Belmatoug N, Hughes DA, Malinova V, Heitner R, Sobreira E, Mrsi\u0107 M, Granovsky-Grisaru S, Amato D, vom Dahl S. The female gaucher patient: the impact of enzyme replacement therapy around key reproductive events (menstruation, pregnancy and menopause). Blood Cells Mol Dis. 2009;43:264\u201388. https:\/\/doi.org\/10.1016\/j.bcmd.2009.04.003.","journal-title":"Blood Cells Mol Dis"},{"key":"3684_CR15","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.ijoa.2004.05.003","volume":"13","author":"A Ioscovich","year":"2004","unstructured":"Ioscovich A, Elstein Y, Halpern S, Vatashsky E, Grisaru-Granovsky S, Elstein D. Anesthesia for obstetric patients with gaucher disease: survey and review. Int J Obstet Anesth. 2004;13:244\u201350. https:\/\/doi.org\/10.1016\/j.ijoa.2004.05.003.","journal-title":"Int J Obstet Anesth"},{"key":"3684_CR16","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1160\/TH10-07-0503","volume":"105","author":"MJ Simchen","year":"2011","unstructured":"Simchen MJ, Oz R, Shenkman B, Zimran A, Elstein D, Kenet G. Impaired platelet function and peripartum bleeding in women with gaucher disease. Thromb Aemost. 2011;105:509\u201314. https:\/\/doi.org\/10.1160\/TH10-07-0503.","journal-title":"Thromb Aemost"},{"key":"3684_CR17","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1002\/jbmr.3734","volume":"34","author":"D Hughes","year":"2019","unstructured":"Hughes D, Mikosch P, Belmatoug N, Carubbi F, Cox T, Goker-Alpan O, Kindmark A, Mistry P, Poll L, Weinreb N, Deegan P. Gaucher disease in bone: from pathophysiology to practice. J Bone Min Res. 2019;34:996\u20131013. https:\/\/doi.org\/10.1002\/jbmr.3734.","journal-title":"J Bone Min Res"},{"key":"3684_CR18","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/s11657-022-01077-x","volume":"17","author":"AY Lujano-Negrete","year":"2022","unstructured":"Lujano-Negrete AY, Rodr\u00edguez-Ruiz MC, Skinner-Taylor CM, Perez-Barbosa L, Cardenas de la Garza JA, Garc\u00eda-Hern\u00e1ndez PA, Espinosa-Banuelos LG, Gutierrez-Leal LF, Jezzini-Mart\u00ednez S, Galarza-Delgado D\u00c1. Bone metabolism and osteoporosis during pregnancy and lactation. Arch Osteoporos. 2022;17:36. https:\/\/doi.org\/10.1007\/s11657-022-01077-x.","journal-title":"Arch Osteoporos"},{"key":"3684_CR19","doi-asserted-by":"publisher","first-page":"175023","DOI":"10.1016\/j.ejphar.2022.175023","volume":"926","author":"W Kong","year":"2022","unstructured":"Kong W, Lu C, Ding Y, Meng Y. Update of treatment for gaucher disease. Eur J Pharmacol. 2022;926:175023. https:\/\/doi.org\/10.1016\/j.ejphar.2022.175023.","journal-title":"Eur J Pharmacol"},{"key":"3684_CR20","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s10545-008-0779-z","volume":"31","author":"TM Cox","year":"2008","unstructured":"Cox TM, Aerts JM, Belmatoug N, Cappellini MD, vom Dahl S, Goldblatt J, Grabowski GA, Hollak CE, Hwu P, Maas M, Martins AM, Mistry PK, Pastores GM, Tylki-Szymanska A, Yee J, Weinreb N. Management of non-neuronopathic gaucher disease with special reference to pregnancy, splenectomy, bisphosphonate therapy, use of biomarkers and bone disease monitoring. J Inherit Metab Dis. 2008;31:319\u201336. https:\/\/doi.org\/10.1007\/s10545-008-0779-z.","journal-title":"J Inherit Metab Dis"},{"key":"3684_CR21","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ejogrb.2010.12.024","volume":"156","author":"S Granovsky-Grisaru","year":"2011","unstructured":"Granovsky-Grisaru S, Belmatoug N, vom Dahl S, Mengel E, Morris E, Zimran A. The management of pregnancy in gaucher disease. Eur J Obstet Gynecol Reprod Biol. 2011;156:3\u20138. https:\/\/doi.org\/10.1016\/j.ejogrb.2010.12.024.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"Suppl 1","key":"3684_CR22","doi-asserted-by":"publisher","first-page":"S49","DOI":"10.1016\/S0049-3848(15)50443-X","volume":"135","author":"H Rosenbaum","year":"2015","unstructured":"Rosenbaum H. Management of women with gaucher disease in the reproductive age. Thromb Res. 2015;135(Suppl 1):S49\u201351. https:\/\/doi.org\/10.1016\/S0049-3848(15)50443-X. Erratum in: Thromb Res 2015;136:489.","journal-title":"Thromb Res"},{"issue":"Suppl 2","key":"3684_CR23","doi-asserted-by":"publisher","first-page":"S217","DOI":"10.1016\/S0755-4982(09)73663-2","volume":"38","author":"N Belmatoug","year":"2009","unstructured":"Belmatoug N, Heraoui D. Maladie de gaucher et Grossesse [Gaucher disease and pregnancy]. Presse Med. 2009;38(Suppl 2):S217\u201323. https:\/\/doi.org\/10.1016\/S0755-4982(09)73663-2.","journal-title":"Presse Med"},{"key":"3684_CR24","unstructured":"Grupo de trabajo sobre GPC. Elaboraci\u00f3n de gu\u00edas de pr\u00e1ctica cl\u00ednica en el Sistema Nacional de Salud. Manual metodol\u00f3gico [Internet]. Madrid: Plan Nacional para el SNS del MSC. Insti- tuto Aragon\u00e9s de Ciencias de la Salud-IACS. 2016. (Gu\u00edas de pr\u00e1ctica cl\u00ednica en el SNS: IACS N.\u25e6 2016\/0I). Available from: https:\/\/portal.guiasalud.es\/egpc\/manual-elaboracion-actualizacion\/ [accessed 16.04.23]."},{"key":"3684_CR25","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","volume":"336","author":"GH Guyatt","year":"2008","unstructured":"Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso- Coello P, Sch\u00fcnemann HJ, GRADE Working Group. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336:924\u20136.","journal-title":"BMJ"},{"key":"3684_CR26","volume-title":"The RAND\/UCLA appropriateness method user\u2019s manual","year":"2001","unstructured":"Fitch K, Bernstein S, Aguilar MD, Burnand B, LaCalle JR, L\u00e1zaro P, van het Loo M, McDonnelll J, Vader J, Kahan JP, editors. The RAND\/UCLA appropriateness method user\u2019s manual. Santa M\u00f3nica: RAND Health; 2001."},{"key":"3684_CR27","unstructured":"Centers for Disease Control and Prevention. Asplenia and Adult Vaccination [Internet] Available from: https:\/\/www.cdc.gov\/vaccines\/adults\/rec-vac\/health-conditions\/asplenia.html [accessed 26.04.23]."},{"key":"3684_CR28","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1177\/107602960401000301","volume":"10","author":"J Koscielny","year":"2004","unstructured":"Koscielny J, Ziemer S, Radtke H, Schmutzler M, Pruss A, Sinha P, Salama A, Kiesewetter H, Latza R. A practical concept for preoperative identification of patients with impaired primary hemostasis. Clin Appl Thromb Hemost. 2004;10:195\u2013204. https:\/\/doi.org\/10.1177\/107602960401000301.","journal-title":"Clin Appl Thromb Hemost"},{"key":"3684_CR29","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/j.1365-2141.2011.08613.x","volume":"153","author":"G Spectre","year":"2011","unstructured":"Spectre G, Roth B, Ronen G, Rosengarten D, Elstein D, Zimran A, Varon D, Revel-Vilk S. Platelet adhesion defect in type I gaucher disease is associated with a risk of mucosal bleeding. Br J Haematol. 2011;153:372\u20138.","journal-title":"Br J Haematol"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03684-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-025-03684-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03684-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T13:52:03Z","timestamp":1743256323000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-025-03684-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,28]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3684"],"URL":"https:\/\/doi.org\/10.1186\/s13023-025-03684-6","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,28]]},"assertion":[{"value":"12 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Antonio Gonz\u00e1lez-Meneses has received grant for research and honoraria for lectures and travel expenses from Sanofi and Takeda. Ignacio Mar\u00edn Le\u00f3n has received research grants from Sanofi-Genzyme and Rovi, and speaker honorarium from Sanofi-Genzyme. Raquel Yahyaoui has received a speaker honorarium from Sanofi Genzyme and Takeda. Francisco J del Castillo has received research grants and speaker honorarium from Sanofi-Genzyme. Rafael Aporta-Rodr\u00edguez, Alicia Rodr\u00edguez-Fern\u00e1ndez, Enrique J. Calder\u00f3n, Lutgardo Garcia-Diaz, Mar\u00eda Lourdes Hermosin-Ramos and Irene Calder\u00f3n Baturone declare that they have no conflict of interest for the topic of this article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"146"}}